Liver Metastases of Noncolorectal Cancer
Liver métastases of noncolorectal nonneuroendocrine (NCNN) carcinoma should only be resected, if radical removal can be achieved. The surgical procedure does not differ from that of colorectal métastases. The perioperative lethality ranges from o to 8.3%, the morbidity from 6 to 47%. There are no defined standard prognostic factors for patients with métastases of noncolorectal (NC) carcinoma. Patients with métastases of neuroendocrine (NE) carcinoma have a superior prognosis due to the slow progression of the underlying disease. 5 year survival rates of up to 70% have been reported after resection of those métastases. For resections of NCNN métastases 5 year survival rates up to 46% have been documented in smaller series. The value of adjuvant or neoadjuvant therapies as well as local ablative procedures has yet to be defined. The indication to resection of métastases of NC carcinoma requires careful and always individual decision.
KeywordsLiver Metastasis Liver Resection Hepatic Resection Hepatic Metastasis Islet Cell Tumor
Unable to display preview. Download preview PDF.
- 2.Kliche KO, Kubsch K, Raida M, Masri-Zada R, Hoffken K (2002) Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine; The Jena experience in 79 patients. J Cancer Res Clin Oncol 128:516–524PubMedCrossRefGoogle Scholar